KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $73.0 million.

  • Organon's Change in Accured Expenses rose 1406.25% to $73.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.0 million, marking a year-over-year decrease of 24750.0%. This contributed to the annual value of -$101.0 million for FY2024, which is 19901.96% down from last year.
  • According to the latest figures from Q3 2025, Organon's Change in Accured Expenses is $73.0 million, which was up 1406.25% from -$98.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Change in Accured Expenses registered a high of $769.0 million during Q1 2021, and its lowest value of -$559.0 million during Q2 2021.
  • Its 5-year average for Change in Accured Expenses is $27.2 million, with a median of -$8.0 million in 2022.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 344347.83% in 2021, then tumbled by 95000.0% in 2023.
  • Quarter analysis of 5 years shows Organon's Change in Accured Expenses stood at -$57.0 million in 2021, then surged by 212.28% to $64.0 million in 2022, then increased by 6.25% to $68.0 million in 2023, then tumbled by 207.35% to -$73.0 million in 2024, then skyrocketed by 200.0% to $73.0 million in 2025.
  • Its Change in Accured Expenses stands at $73.0 million for Q3 2025, versus -$98.0 million for Q2 2025 and $39.0 million for Q1 2025.